Volume 14 Issue 5
Sep.  2023
Turn off MathJax
Article Contents
NING Yating, MAO Leili, LI Wei, XU Jiajun, XU Yingchun, ZHANG Li. Clinical Evaluation of a Fluorescence Immunochromatographic Assay for Interleukin-6 Detection[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(5): 1011-1016. doi: 10.12290/xhyxzz.2023-0186
Citation: NING Yating, MAO Leili, LI Wei, XU Jiajun, XU Yingchun, ZHANG Li. Clinical Evaluation of a Fluorescence Immunochromatographic Assay for Interleukin-6 Detection[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(5): 1011-1016. doi: 10.12290/xhyxzz.2023-0186

Clinical Evaluation of a Fluorescence Immunochromatographic Assay for Interleukin-6 Detection

doi: 10.12290/xhyxzz.2023-0186
Funds:

National High Level Hospital Clinical Research Funding 2022-PUMCH-A-137

More Information
  • Corresponding author: ZHANG Li, E-mail: zhanglipumchlab@163.com
  • Received Date: 2023-04-10
  • Accepted Date: 2023-07-18
  • Publish Date: 2023-09-30
  •   Objective  To evaluate the performance of a new fluorescence immunochromatographic assay for interleukin-6 (IL-6) detection.  Methods  A total of 104 serum samples from patients with suspected infections and normal population were collected at Peking Union Medical College Hospital in December, 2021. Assay A (Wanfu biofluorescence immunochromatography assay) and B (Siemens chemiluminescence assay) were used as references to evaluate the equivalence of the Innova assay for detecting serum IL-6. Meanwhile, 39 homologous paired plasma and serum were collected to evaluate the consistency of the Innova assay in detecting IL-6 content in different types of samples.  Results  In quantitative analysis, two samples were excluded because the content was above the limit of detection for method B. Compared with the assay A or B, the regression equations of the Innova assay were Y=-7.0950+1.1924X (R2=0.9448), Y=-2.6143+1.3072X (R2=0.9391), and the Pearson correlation coefficients were 0.9720 and 0.9691, respectively. With assay A or B as reference, the Innova assay showed the Bland-Altman bias values of -3.0 and 8.0, while the expected bias at the medical decision level (7 ng/L) was -1.44 ng/L (95% CI: -5.37 to 2.50), 1.97 ng/L (95% CI: -2.09 to 6.01), respectively, with 95% CI intervals all included permissible errors (±15%, -1.05 to 1.05 ng/L). The qualitative results showed the high total coincidence rate between the Innova assay and assay A (84.6%), and assay B (83.7%). In addition, the consistency of the Innova assay was good for 39 homologous pairs of plasma and serum samples (P < 0.0001). Only one data (2.6%, 1/39) was identified by Bland-Altman bias analysis to be outside the maximum allowable error range.  Conclusions  Compared with the two reference assays with the same or different principles used in clinical practice, the Innova assay for IL-6 detection has good consistency and correlation, and its test results are almost not affected by the type of serum/plasma samples. To a certain extent, the Innova assay meets the needs of rapid detection in clinical practice.
  • loading
  • [1] Hirano T. IL-6 in inflammation, autoimmunity and cancer[J]. Int Immunol, 2021, 33: 127-148. doi:  10.1093/intimm/dxaa078
    [2] Hunter CA, Jones SA. IL-6 as a keystone cytokine in health and disease[J]. Nat Immunol, 2015, 16: 448-457. doi:  10.1038/ni.3153
    [3] Giraldez MD, Carneros D, Garbers C, et al. New insights into IL-6 family cytokines in metabolism, hepatology and gastroenterology[J]. Nat Rev Gastroenterol Hepatol, 2021, 18: 787-803. doi:  10.1038/s41575-021-00473-x
    [4] Choy E, Calabrese LH. Neuroendocrine and neurophysiological effects of interleukin 6 in rheumatoid arthritis[J]. Rheumatology (Oxford), 2018, 57: 1885-1895. doi:  10.1093/rheumatology/kex391
    [5] Jones SA, Jenkins BJ. Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer[J]. Nat Rev Immunol, 2018, 18: 773-789. doi:  10.1038/s41577-018-0066-7
    [6] Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study[J]. Lancet, 2020, 395: 1054-1062. doi:  10.1016/S0140-6736(20)30566-3
    [7] Kang S, Kishimoto T. Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms[J]. Exp Mol Med, 2021, 53: 1116-1123. doi:  10.1038/s12276-021-00649-0
    [8] Han H, Ma Q, Li C, et al. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors[J]. Emerg Microbes Infect, 2020, 9: 1123-1130. doi:  10.1080/22221751.2020.1770129
    [9] Dhar SK, Vishnupriyan K, Damodar S, et al. IL-6 and IL-10 as predictors of disease severity in COVID-19 patients: results from meta-analysis and regression[J]. Heliyon, 2021, 7: e6155.
    [10] 甘世伟, 章晓红, 陈红. 白介素6与冠状病毒肺炎关系的研究进展[J]. 中华临床医师杂志(电子版), 2020, 14: 573-576. https://www.cnki.com.cn/Article/CJFDTOTAL-ZLYD202007021.htm
    [11] 张文琪. 荧光定量免疫层析法检测白介素6的建立及应用[D]. 广州: 华南理工大学, 2017.
    [12] CLSI. EP9-A3: Measurement Procedure Comparison And Bias Estimation Using Patient Samples[S]. Wayne, PA: CISI, 2013.
    [13] CLSI. EP9-A2: Method Comparison and Bias Estimation Using Patient Samples[S]. Wayne, PA: CISI, 2002.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(2)  / Tables(3)

    Article Metrics

    Article views (1175) PDF downloads(30) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return